Evidence map›Paper›PMID 39942601›Full record

ArticleMolecules (Basel, Switzerland)2025

Near-Infrared Light-Responsive Molybdenum Disulfide Nanosheets for Controlling the Release of Nimodipine as NIR-Drug Delivery System.

Mohamed M Abdelghafour, Ágota Deák, Keristina Wagdi K Amin, Zsófia Czimer, Czike Flóra Veronika, Viktória Péter, Róbert Berkecz, Ferenc Bari, László Janovák

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohamed M AbdelghafourDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-7895-4555
Ágota DeákDepartment of Physical Chemistry and Materials Science, University of Szeged, Rerrich Béla tér 1, H-6720 Szeged, Hungary.
Keristina Wagdi K AminDepartment of Physical Chemistry and Materials Science, University of Szeged, Rerrich Béla tér 1, H-6720 Szeged, Hungary.
Zsófia CzimerDepartment of Physical Chemistry and Materials Science, University of Szeged, Rerrich Béla tér 1, H-6720 Szeged, Hungary.
Czike Flóra VeronikaDepartment of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Korányi ´ Fasor 9, H-6720 Szeged, Hungary.
Viktória PéterDepartment of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Korányi ´ Fasor 9, H-6720 Szeged, Hungary.
Róbert BerkeczInstitute of Pharmaceutical Analysis, Faculty of Pharmacy, University of Szeged, Somogyi utca 4, H-6720 Szeged, Hungary.ORCID 0000-0002-9076-2177
Ferenc BariDepartment of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Korányi ´ Fasor 9, H-6720 Szeged, Hungary.
László JanovákDepartment of Physical Chemistry and Materials Science, University of Szeged, Rerrich Béla tér 1, H-6720 Szeged, Hungary.ORCID 0000-0002-2066-319X

Funding

Hungarian Academy of Sciences János Bolyai Research ScholarshipHungarian Scientific Research Fund OTKA K 134334Interdisciplinary Research Development and Innovation University of SzegedNational Research, Development and Innovation Office PD 142293
6 · The paper itself

Abstract

Here, we present a photothermally triggered drug delivery nanosystem MoS

Indexed as

DisulfidesDrug Delivery SystemsInfrared RaysMolybdenumNanostructuresNimodipineChitosanDrug CarriersDrug LiberationHumansChitosanDisulfidesDrug CarriersMolybdenummolybdenum disulfideNimodipinechitosandrug release controlnear-infrared (NIR) light responsivenimodipine

Identifiers

PMID39942601
PMCPMC11820194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.